Drawing showing lesions in brain stem and spinal cord.
GCT team is pleased to announce the end of subject screening for a relapsing-remitting multiple sclerosis trial in Russia.
In total 243 patients were screened by 21 participating sites in 9-month period.
Updated: December 4, 2015
Share this:
Permanent link: https://2022.gctrials.com/news/last-patient-screened/
BD Contact:
Natalia Katsnelson
Senior Director, Business Development
bd@gctrials.com
telephone: +1 609 921 6868
GMT – 05:00 Eastern time
256 Bunn Drive, Suite 6, Princeton, NJ 08540
BD Contact:
Aleksandr Stiblo
Director, Business Development
bd@gctrials.com
telephone: +7 812 703 0008
GMT + 05:00 Moscow time
23/Z Prof. Popova ul, St. Petersburg, 197376 Russia